Skip to main
ANCN
ANCN logo

ANCN P/E Ratio

P/E Ratio as of Dec 4, 2025: -1.33

Average-1.26
Median-1.30
Minimum-1.47
Maximum-1.07
-1.33
0.20 (17.70%)past month
The P/E ratio for ANCN is -1.33 as of Dec 4, 2025. This represents a decrease of -20.83% compared to its 12-month average P/E ratio of -1.68. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Anchiano Therapeutics Ltd - ADR P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Anchiano Therapeutics Ltd - ADR’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anchiano Therapeutics Ltd - ADR to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ANCN P/E Ratio Historic Data

DateStock priceP/E ratio
Dec 1, 2025$2.62-1.41
Nov 3, 2025$2.80-1.18
Oct 1, 2025$2.64-1.11
Sep 2, 2025$3.10-1.31
Aug 1, 2025$4.10-1.73
Jul 1, 2025$4.64-1.96
Jun 2, 2025$5.40-1.79
May 1, 2025$5.48-1.81
Apr 1, 2025$4.16-1.38
Mar 3, 2025$6.04-1.70
Feb 3, 2025$8.52-2.40
Jan 2, 2025$8.52-2.40

ANCN End of Year P/E Ratio

DateP/E ratioChange
2025-1.33-34.80%
2024-2.04+920.00%
2023-0.20-86.84%
2022-1.52-74.11%
2021-5.87+33.71%
2020-4.39

FAQs About Anchiano Therapeutics Ltd - ADR (ANCN) P/E ratio

The latest P/E ratio of ANCN is -1.33, as of Dec 4, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Anchiano Therapeutics Ltd - ADR’s last 12-month average P/E ratio is -1.68, compared to its current P/E ratio of -1.33. This reflects a decrease of -20.83%.

Anchiano Therapeutics Ltd - ADR’s current P/E ratio of -1.33 is lower than its last 12-month average P/E of -1.68. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Anchiano Therapeutics Ltd - ADR’s average P/E ratio over the last 3 years is -1.06. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Anchiano Therapeutics Ltd - ADR’s average P/E ratio over the last 5 years is -2.29. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Anchiano Therapeutics Ltd - ADR (ANCN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.